ATI RN
Cardiovascular Drugs Pharmacology Slideshare Questions
Question 1 of 5
An individual with poststroke depression is receiving an SSRI. What is the rationale for giving the medication at breakfast and again at midday?
Correct Answer: A
Rationale: Correct Answer: A: Prevent insomnia Rationale: 1. SSRIs can cause insomnia as a side effect. 2. Administering the medication in the morning helps prevent insomnia by reducing the likelihood of disrupting sleep patterns. 3. Giving the medication at midday ensures the drug is still effective during the day without causing sleep disturbances at night. Summary: B: Prevent toxic reactions - Timing of SSRI administration does not directly impact the prevention of toxic reactions. C: Decrease afternoon sleepiness - Administering SSRI at midday may not directly decrease afternoon sleepiness. D: Give an opportunity to monitor behavior closely - Monitoring behavior is important but not directly related to timing of SSRI administration.
Question 2 of 5
The movie Psychedelic Science highlighted the research of neuroscientist Dr Deborah Mash, who led clinical trials to test the use of the African hallucinogen ibogaine for treatment of:
Correct Answer: A
Rationale: The correct answer is A: cocaine dependence. Ibogaine has been studied for its potential to treat addiction, particularly cocaine dependence, due to its effects on the brain's reward system. Dr. Deborah Mash's research focused on this specific application. B: Paranoid schizophrenia is incorrect as ibogaine is not typically used to treat psychotic disorders like schizophrenia. C: Anxiety disorders is incorrect as ibogaine's primary focus is on addiction treatment rather than anxiety. D: Alcohol dependence is incorrect as ibogaine's research has primarily centered on cocaine addiction rather than alcohol dependence.
Question 3 of 5
Which statement represents the most appropriate instructions for a patient with a past suicide attempt who is prescribed amitriptyline (Elavil), 150 mg PO at bedtime?
Correct Answer: A
Rationale: The correct answer is A because picking up a 7-day supply at the pharmacy each week ensures regular monitoring and compliance. This allows healthcare professionals to assess the patient's response to the medication and monitor for any potential side effects or worsening of symptoms. The other choices are incorrect because B does not address the need for regular monitoring, C may not be feasible for all patients and may compromise patient autonomy, and D is impractical and does not provide consistent access to medication.
Question 4 of 5
A client with chronic schizophrenia has had a stroke involving the hippocampus. The client will be discharged on low doses of haloperidol. The nurse who must provide medication teaching will need to adjust the teaching plan to account for client problems with:
Correct Answer: A
Rationale: The correct answer is A: Memory. The hippocampus is crucial for memory formation and retrieval. Since the client's hippocampus is affected by the stroke, they may experience memory deficits. Teaching about medication administration needs to be adjusted to accommodate the client's impaired memory to ensure they understand and remember the instructions. Summary: - Choice A is correct because the hippocampus is involved in memory. - Choice B (Expressive aphasia) is incorrect as it pertains to language expression, not memory. - Choice C (Emotional control) is incorrect as it is not directly related to hippocampal function. - Choice D (Poor balance and coordination) is incorrect as it is not typically associated with hippocampal damage.
Question 5 of 5
A 10-year-old patient will be started on methylphenidate hydrochloride (Ritalin) therapy. The nurse will perform which essential baseline assessment before this drug is started?
Correct Answer: B
Rationale: The correct answer is B: Height and weight. Before starting methylphenidate therapy in a 10-year-old patient, it is essential to assess height and weight as this medication can affect growth and appetite. Monitoring these parameters at baseline helps establish a reference point for future assessment of treatment effects on growth. Eye examination (A) is important for long-term monitoring but not essential before starting therapy. Liver studies (C) are not typically required before starting methylphenidate therapy. Hearing test (D) is not directly related to starting this medication.